Need Training?
Build a solid foundation in science, formulation and product development—find out more!
Most Popular in:
Regulatory
250
New in Regulatory (page 11 of 45)
Mar 30, 2010 | 01:07 PM CDT
Certifying Hair Product Claims
By: Peter D. Kaplan, PhD, and Ram Ramaprasad, PhD,…
Claims for hair products generally are not associated with clear cut outcomes. Therefore, consumers have no standard by which to compare product efficacy. In relation, the North American Hair Research Society (NAHRS) has proposed standards for hair product claims, outlined here, which relate to characteristics including frizz, color fastness and curl retention, among others.
Mar 30, 2010 | 12:15 PM CDT
The FDA's 'Wish List': A Unified Agenda
By: David Steinberg, Steinberg & Associates
The Regulatory Flexibility Act of 1980 and Executive Order 12866 require the publication of a semiannual inventory of the rulemaking under development, and the US Department of Health and Human Services (HHS) publishes this wish list for the FDA. The latest came out on Dec. 7, 2009.
Mar 30, 2010 | 11:54 AM CDT
Function vs. Size: Patenting Nano-scale Cosmetic Invention
By: Jeffrey L. Eichen, Connolly Bove Lodge & Hutz …
Nanometer-scale components are increasingly appearing in cosmetic formulations and a corresponding increase in related patents has occurred. To assist inventors and formulators in protecting nano-scale inventions, this article describes approaches to claimed inventions and illustrates key variables that formulators can monitor and record to give a patent the best chance of later being found valid and infringed.
Mar 19, 2010 | 10:49 AM CDT
Dermatologist Promotes Sunscreen and Antiaging Benefits of Nanotechnology
Nanotechnology can have positive affects on aesthetics, efficacy and delivery when formulated into skin care and sun care products, according to Adnan Nasir, MD, PhD, FAAD, a dermatologist and clinical assistant professor in the department of dermatology at the University of North Carolina.
Mar 16, 2010 | 05:21 PM CDT
Is Cosmetic Science Really "Bad"? Part IV: How Scientific is Cosmetic Science?
By: Johann W. Wiechers, PhD, JW Solutions
Six questions from Michael Shermer’s Baloney Detection Kit have been discussed in this series. The results were not flattering for cosmetic science (read: cosmetic scientists) but cosmetic science did not score badly on all points. Questions seven and eight, described here, discriminate true science from borderland science and non-science or nonsense.
Mar 12, 2010 | 09:38 AM CST
Naturals: Innovation Helps but Lack of Labeling May Hurt
The natural personal care market is more than a passing fad, according to Nancy Mills in her market report for Kline & Co. Despite the growth, she finds that many manufacturers are formulating with more nature-inspired products than truly natural products.
Mar 04, 2010 | 10:15 AM CST
Colorado Judiciary Votes No to Safe Products Act
On March 1, 2010, Colorado's House Committee on Judiciary voted to indefinitely postpone House Bill 10-1248 (HB 1248), or the Colorado Safe Personal Care Products Act.
Mar 03, 2010 | 08:11 AM CST
EU Regulatory Update: CLP Deadlines and Consequences
By: Annelie Struessman, PhD, CONUSBAT
The European Union’s adaptation of the Globally Harmonized System (GHS) is Regulation (EC) No. 1272/2008 on the classification, labeling and packaging (CLP) of substances and mixtures, which entered into force on Jan. 20, 2009.
Feb 26, 2010 | 11:51 AM CST
Translating Data into Claims and Interpreting Regulations: Science vs. Marketing
By: Nava Dayan, PhD, Lipo Chemicals
Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.
Feb 22, 2010 | 03:30 PM CST
Bill Proposes the Colorado Safe Personal Care Products Act
On Feb. 3, 2010, a bill was introduced into the Colorado State Legislature to prohibit the sale of personal care products formulated with chemicals identified as causing cancer or reproductive toxicity.